Researchers discovered why ventricular assist devices (VADs) used to support the left ventricle of cardiogenic shock patients can induce right ventricle dysfunction. They also developed a test that ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data that reinforce the ability of its Decipher Bladder Genomic ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their ...

TARRYTOWN, N.Y.--(BUSINESS WIRE)--A new prognosis claim for the Siemens Healthineers Atellica IM High-Sensitivity Troponin I (TnIH) test 1 immediately advances care for at-risk cardiac patients in the ...

But what if a mouthwash-based test to detect biomarkers can help physicians predict disease recurrence in head and neck cancer patients? That futuristic scenario seems closer to reality after a new ...

After implementation of the 21st Century Cures Act in 2021, 75% of cancer test results were viewed by patients first compared with 37% in 2017, a trends analysis shows. The analysis included the 5.57 ...

Seven years ago, Northeastern graduate Susan Dina Ghiassian was the first employee of Scipher Medicine Corp., a precision medicine company co-founded by Northeastern professor Albert-László Barabási.

Biomerica, Inc. has announced that a landmark peer-reviewed study published in the June 2025 issue of Gastroenterology shows the inFoods® IBS test is an effective personalized dietary therapy for ...